Reacta Biotech develops, manufactures and commercialises oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP). The company was founded in June 2013 by its three founders: Professor Clare Mills, Professor Ashley Woodcock and Peter McPartland.
Reacta Biotech
Biotech company that produces diagnostic kits for food allergy
Company information
Company:
Private
Fund:
EIS Portfolio Service
Sector:
Biotech, Medical, Pharma
Status:
Exited
Investment Date:
03/2014
You might also be interested in...
Highly accredited engineering consultancy providing high-impact work package solutions for critical military platforms
Clinical stage biotech company with a focus on the prevention of life-threatening infections